Abstract:Borderline ovarian tumors (BOTs) are primary epithelial tumors with histological features of malignancy. Clinically, they exhibit a relatively benign course, since they are minimally invasive, and fertility-sparing surgery can be employed 1 . The International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization recognize BOTs as an intermediate entity, referring to them as tumors with 'borderline malignancy' or of 'low malignant potential' 2 . BOTs comprise approximately 4-14% of a… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.